Gilead Sciences (United Kingdom)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (United Kingdom), United Kingdom, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
76%
Total
Publications
254
Total Open
Publications
192
Total
Citations
5.4K
Open Access
Percentage
76%
Total
Publications
254
Total Open
Publications
192
Total
Citations
5.4K
Breakdown
Publisher Open
36%
Both
32%
Other Platform Open
8%
Closed
24%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 35%
61
Hybrid 39%
67
No Guarantees 26%
44
Other Platform Open
Domain 85%
86
Institution 30%
30
Preprint 9%
9
Other Internet 8%
8
Public 3%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 86 |
Europe PMC | Domain | 31 |
University of Bristol - Bristol Research | Institution | 7 |
University of Dundee - Discovery Research Portal | Institution | 4 |
Research Square | Preprint | 4 |
London School of Hygiene and Tropical Medicine - LSHTM Research Online | Institution | 4 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 3 |
University of Nottingham - Repository@Nottingham | Institution | 3 |
University of Milano-Bicocca - BOA - Bicocca Open Archive | Institution | 3 |
The University of Glasgow - Enlighten: Publications | Institution | 3 |